Donald Trump's commerce secretary nominee told his US Senate confirmation hearing Wednesday he favors "across-the-board" tariffs targeting countries rather than products, while signaling a hawkish ...
Cantor Fitzgerald analyst Sarah James maintained a Buy rating on Cigna (CI – Research Report) yesterday and set a price target of $350.00. The ...
Fintel on MSN14h
Cantor Fitzgerald Initiates Coverage of Acrivon Therapeutics (ACRV) with Overweight RecommendationFintel reports that on January 31, 2025, Cantor Fitzgerald initiated coverage of Acrivon Therapeutics (NasdaqGM:ACRV) with a Overweight recommendation. Analyst Price Forecast Suggests 260.44% Upside ...
Cantor Fitzgerald has a convertible bond with Tether, incoming Commerce Secretary Howard Lutnick said at his confirmation hearing, confirming previous reporting by The Wall Street Journal that ...
Cantor Fitzgerald analyst C J Muse maintained a Hold rating on Intel (INTC – Research Report) yesterday and set a price target of $22.00. The ...
Cantor Fitzgerald LP’s lawsuit alleging a firm founded by four of its former investment bankers stole clients worth millions of dollars in profit was dismissed by a New York judge.
Cantor Fitzgerald upgraded shares of Zevra Therapeutics (NASDAQ:ZVRA – Free Report) to a strong-buy rating in a research note issued to investors on Wednesday,Zacks.com reports. Other equities ...
Cantor Fitzgerald currently has a “Overweight” rating and a $9.00 target price on the stock. The consensus estimate for Prenetics Global’s current full-year earnings is ($3.30) per share ...
Hosted on MSN2d
Cantor Fitzgerald Upgrades Beam Therapeutics (BEAM)Fintel reports that on January 29, 2025, Cantor Fitzgerald upgraded their outlook for Beam Therapeutics (NasdaqGS:BEAM) from Neutral to Overweight. Analyst Price Forecast Suggests 87.91% Upside As of ...
This month, Flagstar offloaded $142 million of that portfolio, finding a buyer in Howard Lutnick’s Cantor Fitzgerald, PincusCo reported. A spokesperson for Cantor Fitzgerald did not return a ...
In preparation for the launch, Cantor Fitzgerald hosted a discussion with a Senior Director of Product Development at UnitedHealth (NYSE:UNH). The conversation provided insights into the coverage ...
On Wednesday, Cantor Fitzgerald adjusted its price outlook for Meta Platforms Inc. shares (NASDAQ: NASDAQ:META), setting the new target at $720, a slight decrease from the previous $730 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback